EDGAR Filing Documents for 0001493152-21-009411

Form 8-K - Current report:

SEC Accession No. 0001493152-21-009411

Filing Date

2021-04-22

Accepted

2021-04-21 21:56:36

Documents

Period of Report

2021-04-16

Items

Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	106434
2		ex3-1.htm	EX-3.1	304814
3		ex3-2.htm	EX-3.2	21607
4		ex3-3.htm	EX-3.3	93000
5		ex10-3.htm	EX-10.3	186119
6		ex10-4.htm	EX-10.4	68445
7		ex10-5.htm	EX-10.5	72161
8		ex10-6.htm	EX-10.6	53209
9		ex99-1.htm	EX-99.1	26969
	Complete submission text file	0001493152-21-009411.txt		934584

Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036

Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 856-848-8698

MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)